Formulation and in-vitro characterization of zaltoprofen transdermal patch using different polymers

International Journal of Pharmaceutical Sciences Review and Research

Volumn 27, Issue 1, 2014, Pages 277-282

  Chatterjee, A ^a   Mohan, S ^a   Varshney, Himanshu M ^a   Jaimini, M ^a   Chauhan, Bhupendra S ^a  

^a Jaipur College of Pharmacy   (India)

Author keywords

Hydroxy propyl methyl cellulose (HPMC K 100M); In vitro drug release; Polyvinyl alcohol (PVA); Polyvinyl pyrollidone (PVP K 30); Transdermal drug delivery; Zaltoprofen

Indexed keywords

MACROGOL 400; POLYMER; POVIDONE; PROPYLENE GLYCOL; ZALTOPROFEN;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CONTENT UNIFORMITY; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; EXCIPIENT COMPATIBILITY; FOLDING ENDURANCE; HARDNESS; INFRARED SPECTROSCOPY; MOISTURE; PATCH THICKNESS; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; SURFACE FLATNESS; TENSILE STRENGTH; TRANSDERMAL PATCH; ULTRAVIOLET SPECTROSCOPY; WEIGHT VARIATION;

EID: 84904264442     PISSN: 0976044X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Robinson JR, Lee VH, Controlled Drug Delivery: Fundamentals and Applications, Marcel Dekker, New York, 1987, 523-552.
2. Prausnitz M, Mitragotri S, Langer R, Current status and future potential of transdermal drug delivery, Nature Reviews, 3, 2004, 115-124.
3. Aqil M, Ali A, Sultana Y, Dubey K, Najmi AK, Pillai KK, In vivo characterization of monolithic matrix type transdermal drug delivery systems of Pinacidil monohydrate: A technical note, AAPS Pharm Sci Tech, 7(1), 2006, E1-E5.
4. Kanikannan N, Andega S, Burton S, Babu RJ, Singh M, Drug Dev. Ind. Pharm, 30, 2004, 205-212.
5. Williams AC, Barry BW, Skin absorption enhancers, Reviews in Therapeutic Drug Carrier Systems, 9, 1992, 305-353.
6. Chien YW, Transdermal controlled systemic medications. 1st Ed. New York: Marcel Dekker, 1987.
7. Ministry of health, labor and welfare, Government of Japan, The Japanese pharmacopeia, 15th Edition, 2006, 1242-1243, 1517, 1654.
8. Li L, Ma P, Cao Y, Tao L, Tao Y, Single-dose and multipledose pharmacokinetics of zaltoprofen after oral administration in healthy Chinese volunteers, Journal of Biomedical Research, 25, 2011, 56-62.
9. Silverstein RM, Webster FX, Kiemle DJ, Spectrometric identification of organic compounds, John Wiley & sons, Inc., New Jersey, 2005, 78-80.
10. Skoog DA, Holler JE, Crouch SR, Principles of instrumental analysis, Thomson Higher education, Belmont, 2007, 900-903.
11. Kumar AJ, et al., Transdermal Drug Delivery System: An Overview, International Journal of Pharmaceutical Sciences Review and Research, 3(2), 2010, 49-54.
12. Bharkatiya M et al., Designing and Characterization of Drug Free Patches for Transdermal Application, Int J Pharma Sci Drug Res, 2(1), 2010, 35-39.
13. Ramarao P, Ramakrishna S, Diwan PV, Drug release kinetics from polymeric films containing Propranolol hydrochloride for transdermal use, Pharm Dev Tech, 5(4), 2000, 465-472.
14. Mamatha T, Venkateswara RJ, Mukkanti K, Ramesh G, Transdermal drug delivery for Atomoxetine hydrochloridein vitro and ex vivo evaluation, Current Trends in Biotechnology and Pharmacy, 3(2), 2009, 188-196.
15. Gupta R, Biswajit M, Development and in-vitro evaluation of Diltiazem hydrochloride transdermal patches based on povidone-ethylcellulose matrices, Drug Dev Ind Pharm, 29(1), 2003, 1-7.
16. Samanta MK, Dube R, Suresh B, Transdermal drug delivery system of Haloperidol to overcome self induced extrapyramidal syndrome, Drug Dev Ind Pharm, 29(4), 2003, 405-415.
17. Saini TR, Seth AK, Agrawal GP, Evaluation of free films, Indian drugs, 23(1), 1985, 45-47.
18. Raghuraman S, Velrajan R, Ravi B, Jeyabalan D, Benito J, Sankar V, Design and evaluation of Propranolol hydrochloride buccal films. Indian J Pharm Sci, 64(1), 2002, 32-36.
19. Bhatt DC, Dhake AS, Khar RK, Mishra DN, Development and in-vitro evaluation of transdermal matrix films of metoprolol tartrate, Yakugaku Zasshi, 128, 2008, 1325-31.
20. Bottenberg P, Cleymact R, Muynck CD, Remon JP, Coomans D, Michotte Y, et al., Development and testing of bioadhesive fluoride containing slow release tablets for oral use. J Pharm Pharmacol, 43, 1991, 457-464.
21. Keshary PR, Chien YW, Mechanism of transdermal nitroglycerin administration: development of finite dosing skin permeation system, Drug Dev Ind Pharm, 10(6), 1984, 883-913.